Trial · NCT03078075
Participant flow15
How many started, completed or left each group, period by period.
1 to 15 of 15
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Stage 1 Placebo Non-responders Re-randomized to Placebo at Stage 2 | 111 | |
| Overall Study | STARTED | Stage 1 Placebo Non-responders Re-randomized to AMC at Stage 2 | 114 | |
| Overall Study | STARTED | Stage 1 Placebo Non-responders Not Re-randomized at Stage 2 | 59 | |
| Overall Study | STARTED | Stage 1 Placebo Responders Not Re-randomized at Stage 2 | 10 | |
| Overall Study | STARTED | Stage 1 AMC Remaining on AMC at Stage 2 | 109 | |
| Overall Study | COMPLETED | Stage 1 Placebo Non-responders Re-randomized to Placebo at Stage 2 | 106 | |
| Overall Study | COMPLETED | Stage 1 Placebo Non-responders Re-randomized to AMC at Stage 2 | 103 | |
| Overall Study | COMPLETED | Stage 1 Placebo Non-responders Not Re-randomized at Stage 2 | 19 | |
| Overall Study | COMPLETED | Stage 1 Placebo Responders Not Re-randomized at Stage 2 | 9 | |
| Overall Study | COMPLETED | Stage 1 AMC Remaining on AMC at Stage 2 | 78 | |
| Overall Study | NOT COMPLETED | Stage 1 Placebo Non-responders Re-randomized to Placebo at Stage 2 | 5 | |
| Overall Study | NOT COMPLETED | Stage 1 Placebo Non-responders Re-randomized to AMC at Stage 2 | 11 | |
| Overall Study | NOT COMPLETED | Stage 1 Placebo Non-responders Not Re-randomized at Stage 2 | 40 | |
| Overall Study | NOT COMPLETED | Stage 1 Placebo Responders Not Re-randomized at Stage 2 | 1 | |
| Overall Study | NOT COMPLETED | Stage 1 AMC Remaining on AMC at Stage 2 | 31 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03078075/flow